help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBlanc, J. K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBlanc, J. K.
American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 401, (2005)
© 2005 American Thoracic Society


Correspondence

Endoscopic Ultrasound Staging of Lung Cancer

From the Authors:

We would like to thank Dr. Wallace for his insightful comments regarding our study (1). The aim of our study was to determine the role of EUS and EUS-guided fine needle aspiration (EUS-FNA) in patients with non–small-cell lung cancer (NSCLC) without mediastinal lymphadenopathy who would otherwise proceed directly to surgery. We learned that mediastinal lymph node echocharacteristics are poor predictors of malignancy. In mediastinal lymph node regions accessible to EUS our sensitivity was 42%. We agree that tissue sampling of all mediastinal lymph nodes (malignant-appearing and benign-appearing) would likely result in a higher sensitivity of EUS in staging the mediastinum, as benign-appearing lymph nodes may harbor malignancy. Sampling of all mediastinal lymph nodes, however, increases procedure time, and we question the cost effectiveness as separate needles (approximately $200 each) would be required. It is interesting that despite differences in sensitivity, the detection rate of unresectable disease was 25% in both of our studies (1, 2). Further, metastases were found in regions that are not routinely interrogated during thoractomy (adrenal gland and celiac lymph nodes).

We feel that recommendations on the utility of EUS in staging NSCLC with respect to tumor location are still premature, as tumor location may be a predictor of nodal metastases that can be sampled with EUS-FNA. Unlike Wallace and coworkers' recent study, we found that lower lobe and hilar tumors (versus left upper lobe tumors) were more likely to have metastases to mediastinal lymph nodes accessible to EUS. This is similar to unpublished data from the University of Alabama, Birmingham group, which showed that lower lobe tumors were six times more likely to have malignant mediastinal lymph nodes accessible to EUS-FNA compared with upper lobes (M.A. Eloubeidi, personal communication). It is our hypothesis that EUS-FNA could be directed toward patients with primary tumors in the lower and hilar lobes, and thus ultimately be cost effective in staging NSCLC. The standard of care in NSCLC staging is evolving, and certainly further studies examining the clinical and economic impact of EUS in staging NSCLC are needed so that management of patients with NSCLC is optimized.

Julia Kim LeBlanc

Indiana University Medical Center, Indianapolis, Indiana

FOOTNOTES

Conflict of Interest Statement: J.K.L. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

REFERENCES

  1. LeBlanc JK, Devereaux BM, Imperiale TF, Kesler K, DeWitt JM, Cummings O, Ciaccia D, Sherman S, Mathur P, Conces D, et al. Endoscopic ultrasound in non-small cell lung cancer and negative mediastinum on computed tomography. Am J Respir Crit Care Med 2005;171:177–182.[Abstract/Free Full Text]
  2. Wallace MB, Ravenel J, Block MI, Fraig M, Silvestri G, Wildi S, Schmulewitz N, Varadarajulu S, Roberts S, Hoffman BJ, et al. Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography. Ann Thorac Surg 2004;77:1763–1768.[Abstract/Free Full Text]
  3. Cerfolio RJ, Bryant AS, Eloubeidi MA, Bartolucci AA. Improving the inaccuracies of clinical staging of patients with NSCLC: A prospective trial. Abstract presented at Society of Thoracic Surgeons meeting; January 2005; Tampa, FL.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBlanc, J. K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBlanc, J. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society